Morgan Stanley’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,300
Closed -$41.8K 8191
2024
Q3
$41.8K Sell
2,300
-4,466
-66% -$77.9K ﹤0.01% 6269
2024
Q2
$163K Buy
6,766
+682
+11% +$21.2K ﹤0.01% 5760
2024
Q1
$265K Sell
6,084
-11,587
-66% -$480K ﹤0.01% 5616
2023
Q4
$721K Buy
17,671
+6,833
+63% +$372K ﹤0.01% 5457
2023
Q3
$897K Sell
10,838
-2,507
-19% -$228K ﹤0.01% 4862
2023
Q2
$1.27M Buy
13,345
+462
+4% +$59.3K ﹤0.01% 4685
2023
Q1
$1.78M Buy
12,883
+7,066
+121% +$646K ﹤0.01% 4533
2022
Q4
$417K Sell
5,817
-5,650
-49% -$534K ﹤0.01% 5332
2022
Q3
$1.35M Buy
11,467
+479
+4% +$85.3K ﹤0.01% 4684
2022
Q2
$2M Buy
10,988
+5,234
+91% +$951K ﹤0.01% 4539
2022
Q1
$1.35M Sell
5,754
-3,863
-40% -$780K ﹤0.01% 4786
2021
Q4
$3.28M Buy
9,617
+1,592
+20% +$877K ﹤0.01% 4170
2021
Q3
$5.24M Sell
8,025
-155
-2% -$114K ﹤0.01% 3635
2021
Q2
$8.2M Buy
8,180
+1,639
+25% +$1.63M ﹤0.01% 3223
2021
Q1
$9.88M Buy
6,541
+6,469
+8,985% +$10.5M ﹤0.01% 2668
2020
Q4
$67K Buy
72
+68
+1,700% +$36.5K ﹤0.01% 6062
2020
Q3
$1K Buy
+4
New +$1.59K ﹤0.01% 6683

Other funds holding DNMR

Morgan Stanley's DNMR Position: Q4 2024 in Review

Morgan Stanley sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 2,300 shares — an estimated $41.8K sold.

Morgan Stanley first reported a position in DNMR in Q3 2020 and held it in 17 quarters. The position peaked at $9.88M in Q1 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Morgan Stanley reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 2,300 Danimer Scientific, Inc. shares in Q4 2024, an estimated $41.8K.
  • Morgan Stanley first reported a position in Danimer Scientific, Inc. in Q3 2020 and held it in 17 quarters.
  • Morgan Stanley's Danimer Scientific, Inc. position peaked at $9.88M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.